Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency.

BACKGROUND Left ventricular function after acute myocardial infarction (AMI) is determined by the expansion of the infarct zone and remodeling of the noninfarcted myocardium. An occluded infarct-related artery (IRA) is an independent risk factor for remodeling. METHODS AND RESULTS Changes in myocardial collagen metabolism were evaluated in 36 patients with suspected AMI. The plasma creatine kinase MB fraction and myoglobin release curves were analyzed for assessment of early reperfusion and infarct size. Collagen scar formation was evaluated by measurement of serum concentrations of the aminoterminal propeptide of type III procollagen (PIIINP), the aminoterminal propeptide of type I procollagen (intact PINP), and the carboxyterminal propeptide of type I procollagen (PICP). Plasma renin activity and urine excretion of cortisol and aldosterone were also measured. Coronary angiography and left ventricular cineangiography were performed during early hospitalization. The serum concentration of PIIINP increased from 3.50+/-0.20 to a maximum of 5.08+/-0.36 microg/L (n=32) in the patients with AMI, whereas the concentrations of intact PINP and PICP tended to decrease. The area under the curve (AUC) of PIIINP during the first 10 postinfarction days was larger in patients with severe heart failure or ejection fractions < or = 40% than in those with no heart failure or with an ejection fraction > 40% (P<.05 and P<.01, respectively), and it was also larger in the patients with TIMI grade 0 to 2 flows than in those with TIMI 3 flows (P<.05), despite similar enzymatically determined infarct sizes. No significant correlations between PIIINP and neurohumoral parameters were observed. The AUC of PIIINP and the change in PIIINP during the first 4 days were significantly correlated with indices of cardiac function. CONCLUSIONS Collagen scar formation after AMI can be quantified by measurement of serum PIIINP concentrations. Scar formation is more prominent in large infarctions causing left ventricular dysfunction and in patients with occluded IRAs.

[1]  G. Lamas,et al.  Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. , 1995, Circulation.

[2]  M. Hori,et al.  Late Reperfusion for Acute Myocardial Infarction Limits the Dilatation of Left Ventricle Without the Reduction of Infarct Size , 1993, Circulation.

[3]  A. L. Simon,et al.  Left Ventricular Size after Acute Myocardial Infarction: Serial Changes and their Prognostic Significance , 1973, Circulation.

[4]  W Grossman,et al.  Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. , 1986, Circulation.

[5]  J. Risteli,et al.  Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. , 1995, Journal of hepatology.

[6]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[7]  J. Risteli,et al.  Collagen propeptides as indicators of collagen assembly. , 1995, Acta orthopaedica Scandinavica. Supplementum.

[8]  A W Wiegner,et al.  Effects of reperfusion after coronary artery occlusion on post-infarction scar tissue. , 1985, Circulation research.

[9]  J. Rouleau,et al.  Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. , 1994, Journal of the American College of Cardiology.

[10]  J. Risteli,et al.  Thrombolytic Therapy With Streptokinase Stimulates Collagen Breakdown , 1991, Circulation.

[11]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[12]  J. Risteli,et al.  Immunoassay for intact amino-terminal propeptide of human type I procollagen. , 1996, Clinical chemistry.

[13]  S. Hohnloser,et al.  Analysis of Creatine Kinase, CK‐MB, Myoglobin, and Troponin T Time‐Activit Curves for Early Assessment of Coronary Artery Reperfusion After Intravenous Thrombolysis , 1993, Circulation.

[14]  S. Kawashima,et al.  Effects of late reperfusion on infarct expansion and infarct healing in conscious rats. , 1993, The American journal of pathology.

[15]  J. Díez,et al.  Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. , 1995, Circulation.

[16]  J. Risteli,et al.  Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator. , 1996, American heart journal.

[17]  K. Weber,et al.  Connective tissue: a metabolic entity? . , 1995, Journal of molecular and cellular cardiology.

[18]  T. Christian,et al.  Determinants of infarct size in acute myocardial infarction in patients treated with reperfusion therapy. , 1996, Current opinion in cardiology.

[19]  L. Ceremużyński.  Hormonal and metabolic reactions evoked by acute myocardial infarction. , 1981, Circulation research.

[20]  J. Gore,et al.  Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction. , 1987, The American journal of cardiology.

[21]  M. Daemen,et al.  The alpha-smooth muscle actin-positive cells in healing human myocardial scars. , 1994, The American journal of pathology.

[22]  J. Risteli,et al.  Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. , 1990, Clinical chemistry.

[23]  R. Kirsner,et al.  Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts , 1993, Journal of cellular physiology.

[24]  J. Risteli,et al.  Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. , 1988, Clinical chemistry.

[25]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[26]  P. Whittaker.  Unravelling the mysteries of collagen and cicatrix after myocardial infarction. , 1995, Cardiovascular research.

[27]  K. Swedberg,et al.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1992, The New England journal of medicine.

[28]  V. Richard,et al.  Healing of myocardial infarcts in dogs. Effects of late reperfusion. , 1995, Circulation.

[29]  J. Hochman,et al.  Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. , 1987, Circulation.

[30]  R. Kloner,et al.  Altered myocardial states. The stunned and hibernating myocardium. , 1989, The American journal of medicine.

[31]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.

[32]  B. Jugdutt,et al.  Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. , 1995, Circulation.

[33]  K. Weber,et al.  Regulation of collagen degradation in the rat myocardium after infarction. , 1995, Journal of molecular and cellular cardiology.

[34]  H. Katus,et al.  Non-invasive assessment of infarct reperfusion: the predictive power of the time to peak value of myoglobin, CKMB, and CK in serum. , 1988, European heart journal.

[35]  P. Toft,et al.  Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction. , 1990, Circulation.

[36]  H. Weisman,et al.  Limitation of Infarct Expansion and Ventricular Remodeling by Late Reperfusion Study of Time Course and Mechanism in a Rat Model , 1993, Circulation.

[37]  R. Jeremy,et al.  Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. , 1987, Journal of the American College of Cardiology.

[38]  G. Lamas,et al.  Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. , 1988, The New England journal of medicine.

[39]  S. Jensen,et al.  The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction. , 1995, The American journal of cardiology.

[40]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[41]  E. Braunwald,et al.  Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. , 1993, Circulation.

[42]  H. Swan,et al.  Effects of nonsurgical myocardial reperfusion on plasma creatine kinase kinetics in man. , 1983, American heart journal.

[43]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[44]  O. G. Larsen,et al.  Effect on collagen metabolism of thrombolytic therapy with tissue‐plasminogen activator. A randomized, placebo‐controlled study , 1995, European journal of clinical investigation.

[45]  M. Daemen,et al.  Collagen remodeling after myocardial infarction in the rat heart. , 1995, The American journal of pathology.